ACAD

Q: What is the price of ACADIA Pharmaceuticals (ACAD) today?

The price of ACADIA Pharmaceuticals (ACAD) today is $ 22.20, with return of 44.34% compared to the last year. The price of ACADIA Pharmaceuticals (ACAD) started the year trading around $ 26.71 and today it is at $ 22.20. Follow the real-time price chart, the historical price of ACADIA Pharmaceuticals (ACAD) and international markets.

Q: When does ACADIA Pharmaceuticals (ACAD) pay dividends?

ACADIA Pharmaceuticals (ACAD) did not distribute dividends in the last year.

Q: Is ACADIA Pharmaceuticals (ACAD) worth it?

Currently, ACADIA Pharmaceuticals (ACAD) is priced at $ 22.20, with a P/E of 9.65%, representing a deviation of -1,857% from its historical average P/E. In the last year, the stock showed a variation of 44.34 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 44.34%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy ACADIA Pharmaceuticals (ACAD) stock?

Investing in stocks of ACADIA Pharmaceuticals (ACAD) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of ACADIA Pharmaceuticals (ACAD) yield today?

The yield of ACADIA Pharmaceuticals (ACAD) was -0.89% in the last month, 44.34% in the last year and 7.56% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of ACADIA Pharmaceuticals (ACAD) today, the total investment would be $ 2,220.00, based on the current price of $ 22.20.If past performance were to repeat, the return on your investment would be:In 1 year: $ 3,204.35In 5 years: $ 2,387.83In 10 years: $ 2,220.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ACADIA Pharmaceuticals Inc.

Price

$ 22.20

return (12m)

44.34%

p/e

9.65

p/bv

3.07

DIVIDEND YIELD

0.00%

ACAD price

ACAD

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ACAD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.89%

3 months

-15.56%

1 year

44.34%

2 years

22.99%

5 years

7.56%

10 years

0.00%

Fundamentals ACAD

review the fundamentals of ACADIA Pharmaceuticals shares

P/E

9.65

Sector: -5.82 Industry: -5.82

P/S (PSR)

3.52

Sector: -4.74 Industry: -4.74

P/BV

3.07

Sector: 1.40 Industry: 1.40

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

25.00%

Sector: -72.38% Industry: -72.38%

ROE

31.86%

Sector: -84.15% Industry: -84.15%

ROIC

16.12%

Sector: -1,194.38% Industry: -1,194.38%

NET MARGIN

36.49%

Sector: -46.16% Industry: -46.16%

GROSS MARGIN

91.69%

Sector: 35.92% Industry: 35.92%

OPERATING MARGIN

9.78%

Sector: -46.05% Industry: -46.05%

EV/EBITDA

32.37

Sector: -5.52 Industry: -5.52

EV/EBIT

36.01

Sector: -5.77 Industry: -5.77

PRICE-TO-ASSETS

2.41

Sector: 1.13 Industry: 1.13

BVPS

7.22

Sector: 1.63 Industry: 1.63

EPS

2.30

Sector: -2.73 Industry: -2.73

EQUITY-TO-ASSETS RATIO

0.78

Sector: 0.32 Industry: 0.32

LIABILITIES / ASSETS

0.22

Sector: 0.33 Industry: 0.33

CAGR REVENUE 5 YEARS

17.22%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF ACADIA Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 22.20

Fair Value

$ 0.00

Upside/Downside Return potential.

-12.93%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ACAD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
PFE	20.72	1.73	8.35%	6.07%	$ 161.03 B	12.42%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	25.06	-1,098.65	-4,383.84%	0.36%	$ 108.77 B	1.09%
VRTX	28.19	5.97	21.18%	0.00%	$ 111.43 B	32.94%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ACAD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ACADIA Pharmaceuticals

ACADIA Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (3 people)

United States

33 years

Founded: 1993

2004

Time since IPO - 22 years

601

Employees

The Company ACADIA Pharmaceuticals Inc. (United States), is listed on Nasdaq with a market value of $ 3.77 Billions, having an equity of $ 1.23 Billion.

With a total of 601 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 1.07 Billion, which generated a profit in the amount of $ 391.01 Millions.

As for its main indicators, the Company has a P/E ratio of 9.65, a P/BV ratio of 3.07 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ACAD.

Market cap

$ 3.77 Billions

Net worth

$ 1.23 Billion

US$ 1,227,390,000.00

Assets

$ 1.56 Billion

US$ 1,564,190,000.00

Total Shares Outstanding

170.00 Millions

170,000,000

Average Daily Trading Volume

$ 1.79 Million

US$ 1,785,196.14

Sector

Health Care

Industry

Biotechnology

ACAD

ACAD revenue and profits

Financial Results ACAD

DRAG THE FRAME TO SEE MORE DATA

ACAD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 884.28 29,96% (12M)

P/E

25.06

0.36%

ROE

-4,383.84%

P/BV

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

PFE - Pfizer

$ 28.32 32,24% (12M)

P/E

20.72

6.07%

ROE

8.35%

P/BV

1.73

ABBV - AbbVie

$ 208.84 16,32% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 884.28 29,96% (12 M)

P/L

25.06

0.36%

ROE

-4,383.84%

P/VP

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

PFE - Pfizer

$ 28.32 32,24% (12 M)

P/L

20.72

6.07%

ROE

8.35%

P/VP

1.73

ABBV - AbbVie

$ 208.84 16,32% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

Frequently Asked Questions

What is the price of ACADIA Pharmaceuticals (ACAD) today?

The price of ACADIA Pharmaceuticals (ACAD) today is $ 22.20, with return of 44.34% compared to the last year. The price of ACADIA Pharmaceuticals (ACAD) started the year trading around $ 26.71 and today it is at $ 22.20. Follow the real-time price chart, the historical price of ACADIA Pharmaceuticals (ACAD) and international markets.

When does ACADIA Pharmaceuticals (ACAD) pay dividends?

ACADIA Pharmaceuticals (ACAD) did not distribute dividends in the last year.

Is ACADIA Pharmaceuticals (ACAD) worth it?

Currently, ACADIA Pharmaceuticals (ACAD) is priced at $ 22.20, with a P/E of 9.65%, representing a deviation of -1,857% from its historical average P/E. In the last year, the stock showed a variation of 44.34 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 44.34%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy ACADIA Pharmaceuticals (ACAD) stock?

Investing in stocks of ACADIA Pharmaceuticals (ACAD) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of ACADIA Pharmaceuticals (ACAD) yield today?

The yield of ACADIA Pharmaceuticals (ACAD) was -0.89% in the last month, 44.34% in the last year and 7.56% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of ACADIA Pharmaceuticals (ACAD) today, the total investment would be $ 2,220.00, based on the current price of $ 22.20.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 3,204.35
In 5 years: $ 2,387.83
In 10 years: $ 2,220.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ACAD

ACADIA Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ACAD

review the fundamentals of ACADIA Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT ACADIA Pharmaceuticals

ACADIA Pharmaceuticals Inc.

United States

33 years

2004

601

PROFIT X PRICE ACAD

Financial Results ACAD

ACAD cash flow

Asset, Revenue and Profit Growth - ACAD

ACAD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions